In 2022, a systematic study evaluating the effectiveness of CD70-targeted CAR-T cells in a GBM mouse model demonstrated that CD70 plays a crucial role in the sphere formation and value addition of GBM [82]. This evidence concerns the gene CD70 and glioblastoma.